The National Institutes of Health is seeking men (ages 18-24 years) with fragile X syndrome for a research study at the NIH Clinical Center in Bethesda, Maryland.

This study is preliminary to doing brain imaging in subjects with fragile X syndrome. In this study we will determine how well men with fragile X syndrome can accept lying down in a scanner.

This study has minimal risk, requires one outpatient visit lasting about 4 hours, and participants will be compensated.

For more information call or e-mail Dr. Bishu at 301-402-5295 or bishus@mail.nih.gov
Refer to study 06-M-0214
posted 4/18/08. More information at www.clinicaltrials.gov

The purpose of this study is to test aripiprazole (Abilify) in the treatment of children and adolescents with FXS. The investigators, Dr. Christopher McDougle and Dr. Craig Erickson, believe that aripiprazole will be effective in decreasing aggression, self-injurious behavior, agitation, and repetitive behavior commonly observed in individuals with FXS. Ages 6 to 35 are eligible.

This study is funded by FRAXA. More information at www.clinicaltrials.gov

Researchers at The University of Wisconsin - Madison and The Waisman Center would like to invite adolescent girls (ages 13-20 years) with fragile X to participate in a social communication study.

Travel to Madison, Wisconsin for the study will be paid for.

If you would like more information regarding this research project please contact the Communication and Cognition Laboratory at 608-262-6904 to learn more. If no one is available when you call please leave your contact information and we will get back to you.